JP Morgan Chase’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-73,500
Closed -$867K 7567
2025
Q4
$867K Buy
73,500
+65,000
+765% +$835K ﹤0.01% 4701
2025
Q3
$135K Buy
+8,500
New +$123K ﹤0.01% 5743
2025
Q1
Sell
-51,000
Closed -$862K 7359
2024
Q4
$862K Hold
51,000
﹤0.01% 4735
2024
Q3
$1.04M Hold
51,000
﹤0.01% 4448
2024
Q2
$1.15M Hold
51,000
﹤0.01% 4175
2024
Q1
$1.34M Buy
51,000
+15,000
+42% +$427K ﹤0.01% 4139
2023
Q4
$1.14M Hold
36,000
﹤0.01% 4241
2023
Q3
$1.01M Buy
+36,000
New +$1.24M ﹤0.01% 4061
2015
Q4
Sell
-10,000
Closed -$65K 4696
2015
Q3
$65K Buy
+10,000
New +$105K ﹤0.01% 3778

Other funds holding CC

JP Morgan Chase's CC Position: Q1 2026 in Review

JP Morgan Chase reduced its Chemours (CC) stake by 3.7% in Q1 2026, selling an estimated $2.53M and leaving 3,800,873 shares worth $80.6M. The position accounts for 0.01% of the portfolio, ranked #1098.

JP Morgan Chase first reported a position in CC in Q3 2015 and has held it in 43 quarters since. The position peaked at $129M in Q2 2023. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • JP Morgan Chase held 3,800,873 shares of Chemours worth $80.6M as of Q1 2026.
  • JP Morgan Chase sold 145,334 Chemours shares in Q1 2026, an estimated $2.53M.
  • Chemours made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1098 holding.
  • JP Morgan Chase first reported a position in Chemours in Q3 2015 and has held it in 43 quarters since.
  • JP Morgan Chase's Chemours position peaked at $129M in Q2 2023.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.